Treatment of GC-DM was necessary for at least 1 month after GC-DM developed, and fasting hypoglycemia in early morning should be monitored after 2 weeks of GC therapy with DPP-4 inhibitors. The gene discussed is DPP4; the disease is diabetes mellitus.